Loading organizations...
Founded in 2003 by Catherine Mott, BlueTree Allied Angels is a Wexford, Pennsylvania-based angel investor group that pools capital from accredited individuals to make equity investments in early-stage startups. Operating under the BlueTree Capital Group umbrella, the network grew to 88 active investors and has deployed over $42 million across 55 startup companies. Beyond its core membership model, the organization supports a $10 million venture fund and raised $12.5 million for its BlueTree Venture Capital Fund I LP in December 2021. The firm targets sectors like health tech, biotech, and artificial intelligence, building a diverse portfolio that includes recognizable names such as Peptilogics, Anglr, and Wombat, its largest return exit. The group's notable investments also feature backing iCarbonX, which reached a $1.6 billion unicorn valuation in 2018, alongside a strong exit when HealthTell was sold to Expedia.
Key people at BlueTree Allied Angels.
BlueTree Allied Angels was founded in 2003 by Catherine Mott (CEO/Founder).
Key people at BlueTree Allied Angels.
BlueTree Allied Angels has 7 tracked investments across 7 companies. The latest tracked deal is $3.0M Seed in Gridwise in February 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2020 | Gridwise | $3.0M Seed | Mountain State Capital | Innovation Works, Austin Ogilvie, 412 Venture Fund, Quaker Capital Investments, Reinforced Ventures, Switch Ventures |
| Aug 25, 2016 | ANGLR | $1.0M Seed | BlueTree Allied Angels | — |
| Dec 19, 2014 | Rinovum Women's Health | $3.0M Series C | — | John Manzetti |
| May 13, 2014 | Gemmus Pharma | $3.3M Series B | — | Life Science Angels, Tech Coast Angels, The Angels' Forum, Wilmington Investor Network |
| Jul 18, 2012 | Neuros Medical | $3.5M Other Equity | Boston Scientific, Stephen R. Haynes | Case Tech Ventures, JumpStart Ventures, Modelvest, North Coast Ventures, Ohio Tech Angel Fund, Physician Investment Group, Queen City Angels, RiverVest Venture Partners |
| Apr 10, 2012 | Voci Technologies | $3.1M Series A | Steve Robinson | Carnegie Mellon University, Innovation Works |
| Apr 15, 2011 | Carmell Therapeutics | $3.0M Series A | Harbor Light Capital | Ariel Southeast Angel Partners, Innovation Works, Newlin Investment Company, Pittsburgh Life Sciences Greenhouse |
BlueTree Allied Angels was founded in 2003 by Catherine Mott (CEO/Founder).
BlueTree Allied Angels is a leading angel investment network based in Western Pennsylvania, founded in 2003. It is a members-only group of accredited investors focused on early-stage, regional companies, primarily in the United States. Their mission centers on supporting promising startups by providing capital and expertise to help them grow. The firm invests across sectors such as software, healthcare, biotechnology, therapeutics, and medical devices, with a portfolio that includes over 40 investments and multiple successful exits. BlueTree Allied Angels plays a significant role in the regional startup ecosystem by connecting investors with innovative companies and fostering growth in emerging technologies[1][2][4].
The group was established to create a collaborative network of private equity investors who meet regularly to evaluate early-stage investment opportunities. Key partners include experienced investors who bring industry knowledge and strategic support to portfolio companies. Over time, BlueTree Allied Angels has evolved to focus on high-potential startups within its geographic region, emphasizing sectors with strong growth potential and technological innovation. This focus has allowed the network to build a track record of supporting companies that address critical market needs, particularly in health tech and software[1][2][4].
BlueTree Allied Angels rides the trend of increasing regional angel investment networks that support early-stage innovation outside traditional tech hubs. The timing is favorable due to growing entrepreneurial activity in Western Pennsylvania and the broader U.S. market’s demand for advancements in healthcare and software solutions. Market forces such as rising startup formation, increased investor interest in early-stage ventures, and the need for specialized sector expertise work in their favor. By fostering local innovation and providing critical early capital, BlueTree Allied Angels influences the broader ecosystem by accelerating technology commercialization and job creation in the region[1][2][4].
Looking ahead, BlueTree Allied Angels is positioned to deepen its impact by expanding its portfolio in high-growth sectors like AI-driven healthcare and autonomous systems safety, as evidenced by recent investments in companies like Edge Case Research. Trends such as AI integration, digital health, and autonomous technologies will likely shape their investment focus. Their influence may grow as they continue to build a robust network of investors and startups, potentially increasing deal flow and follow-on funding opportunities. This evolution will reinforce their role as a critical catalyst for regional innovation and economic development[2][4].
